BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 11, Issue 18
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3605)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series.
Item 
Count 
PDF366
HTML3006
Figures (1-2)233
 Sum=3605
May 14, 2005 (publication date) through Jan 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005; 11(18): 2773-2776 [PMID: 15884120 DOI: 10.3748/wjg.v11.i18.2773]
URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2773.htm
Number Citing Articles
1
Giovanni Latella, Carmelo Scarpignato. Rifaximin in the management of colonic diverticular disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 585 doi: 10.1586/egh.09.63
2
V. L. Martynov, A. Kh. Khairdinov. THE ETHIOPATOGENESIS AND THE ANALYSIS OF AN ANTIBIOTIC TREATMENT OF A SMALL INTESTINE BACTERIAL OVERGROWTH SYNDROME. Bulletin of Siberian Medicine 2015; 14(3): 49 doi: 10.20538/1682-0363-2015-3-49-62
3
R. D'INCÀ, F. POMERRI, M. G. VETTORATO, E. DAL PONT, V. DI LEO, A. FERRONATO, V. MEDICI, G. C. STURNIOLO. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Alimentary Pharmacology & Therapeutics 2007; 25(7): 771 doi: 10.1111/j.1365-2036.2007.03266.x
4
L. Gatta, C. Scarpignato. Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics 2017; 45(5): 604 doi: 10.1111/apt.13928
5
Hassan Al Harakeh, Abhilash J. Paily, Samer Doughan, Irshad Shaikh. Recurrent Acute Diverticulitis: When to Operate?. Inflammatory Intestinal Diseases 2018; 3(2): 91 doi: 10.1159/000494973
6
Sergio Peralta, Claudia Cottone, Tiziana Doveri, Piero Luigi Almasio, Antonio Craxi. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin. World Journal of Gastroenterology 2009; 15(21): 2628-2631 doi: 10.3748/wjg.15.2628
7
Chia-Chang Chen, Jiann-Sheng Su, Hong-Zen Yeh, Chi-Sen Chang, Yen-Chun Peng, Chih-Wei Tseng, Yu-Tso Chen, Cheng-Li Lin, Chia-Hung Kao. Association Between Colonic Diverticulosis and Erectile Dysfunction. Medicine 2015; 94(47): e2042 doi: 10.1097/MD.0000000000002042
8
Antonio Tursi. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opinion on Pharmacotherapy 2007; 8(3): 299 doi: 10.1517/14656566.8.3.299
9
Thomas R. Ziegler, Conrad R. Cole. Small bowel bacterial overgrowth in adults: A potential contributor to intestinal failure. Current Gastroenterology Reports 2007; 9(6) doi: 10.1007/s11894-007-0060-x
10
Francesca Romana Ponziani, Viviana Gerardi, Antonio Gasbarrini. Diagnosis and treatment of small intestinal bacterial overgrowth. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 215 doi: 10.1586/17474124.2016.1110017
11
Michel Bouchoucha, Marinos Fysekidis, Céline Lekhal, Bakhtiar Daniel Bejou, Jean-Marc Sabate, Robert Benamouzig. COLIGENTA treatment of small intestinal bacterial overgrowth. Results of an open study.. Digestive and Liver Disease 2021; 53(1): 66 doi: 10.1016/j.dld.2020.10.032
12
Julius Špičák, Miloš Kučera, Gabriela Suchánková. Diverticular disease: diagnosis and treatment. Vnitřní lékařství 2018; 64(6): 621 doi: 10.36290/vnl.2018.086
13
Carmelo Scarpignato, Anna Bertelé, Antonio Tursi. Probiotics for the Treatment of Symptomatic Uncomplicated Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1): S70 doi: 10.1097/MCG.0000000000000641
14
Sarah Khan, Lin Chang. Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 2010; 7(10): 565 doi: 10.1038/nrgastro.2010.137
15
Danielle Harari. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 2010; : 909 doi: 10.1016/B978-1-4160-6231-8.10108-4
16
Jessica Cottreau, Shannon F Baker, Herbert L DuPont, Kevin W Garey. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Review of Anti-infective Therapy 2010; 8(7): 747 doi: 10.1586/eri.10.58
17
E.-M. Schmidt, R. Jakobs. Divertikulose und Divertikulitis im Alter. Der Gastroenterologe 2012; 7(4): 320 doi: 10.1007/s11377-012-0660-3
18
H. J. Heppner. Spezifische Aspekte bei Infektionserkrankungen im Alter. Der Gastroenterologe 2021; 16(5): 355 doi: 10.1007/s11377-021-00548-w
19
Erica Cohen, Garth Fuller, Roger Bolus, Rusha Modi, Michelle Vu, Kamyar Shahedi, Rena Shah, Mary Atia, Nicole Kurzbard, Victoria Sheen, Nikhil Agarwal, Marc Kaneshiro, Linnette Yen, Paul Hodgkins, M. Haim Erder, Brennan Spiegel. Increased Risk for Irritable Bowel Syndrome After Acute Diverticulitis. Clinical Gastroenterology and Hepatology 2013; 11(12): 1614 doi: 10.1016/j.cgh.2013.03.007
20
Carmelo Scarpignato, Neil Stollman. Colonic Diverticular Disease. 2022; : 209 doi: 10.1007/978-3-030-93761-4_18
21
Nayoung Kim. The Relationship of Dysbiosis of Duodenal Microbiome and Functional Dyspepsia. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2024; 24(4): 327 doi: 10.7704/kjhugr.2024.0053
22
Antonio Tursi. Colonic microflora imbalance and diverticular disease. Digestive and Liver Disease 2010; 42(6): 458 doi: 10.1016/j.dld.2009.09.003
23
Lisa L Strate, Rusha Modi, Erica Cohen, Brennan M R Spiegel. Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights. American Journal of Gastroenterology 2012; 107(10): 1486 doi: 10.1038/ajg.2012.194
24
Carmelo Scarpignato, Giovanni Barbara, Angel Lanas, Lisa L. Strate. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818771305
25
Alexandra M. Zaborowski, Des C. Winter. Evidence-based treatment strategies for acute diverticulitis. International Journal of Colorectal Disease 2021; 36(3): 467 doi: 10.1007/s00384-020-03788-4
26
Georgia Brown, Emily C. Hoedt, Simon Keely, Ayesha Shah, Marjorie M. Walker, Gerald Holtmann, Nicholas J. Talley. Role of the duodenal microbiota in functional dyspepsia. Neurogastroenterology & Motility 2022; 34(11) doi: 10.1111/nmo.14372
27
E. SCARPELLINI, M. GABRIELLI, C. E. LAURITANO, A. LUPASCU, G. MERRA, G. CAMMAROTA, I. A. CAZZATO, G. GASBARRINI, A. GASBARRINI. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Alimentary Pharmacology & Therapeutics 2007; 25(7): 781 doi: 10.1111/j.1365-2036.2007.03259.x
28
Paul J. Lappinga, Susan C. Abraham, Joseph A. Murray, Emily A. Vetter, Robin Patel, Tsung-Teh Wu. Small Intestinal Bacterial Overgrowth: Histopathologic Features and Clinical Correlates in an Underrecognized Entity. Archives of Pathology & Laboratory Medicine 2010; 134(2): 264 doi: 10.5858/134.2.264
29
Yu. A. Shelygin, V. T. Ivashkin, S. I. Achkasov, A. I. Moskalev, V. M. Тimerbulatov, A. V. Sazhin, S. G. Shapovalyants, O. Y. Karpukhin, N. V. Kostenko, N. N. Кorotkikh, I. V. Zarodnyuk, J. L. Trubacheva, V. V. Veselov, A. A. Likutov, V. N. Kashnikov, S. A. Frolov, P. A. Yartsev, I. D. Loranskaya, B. A. Vykova, O. S. Shifrin, E. A. Poluektova, Z. A. Mamieva, A. I. Ulyanin, T. V. Shkurko. CLINICAL GUIDELINES Diverticular disease (57.2, 57.3), adults. Koloproktologia 2024; 23(2): 10 doi: 10.33878/2073-7556-2024-23-2-10-27
30
Angel Lanas, Daniel Abad-Baroja, Aitor Lanas-Gimeno. Progress and challenges in the management of diverticular disease: which treatment?. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818789055
31
G. Latella. Diverticular Disease: Emerging Evidence in a Common Condition. Falk Symposium 2006; 148: 161 doi: 10.1007/1-4020-4318-X_20
32
Hendrike E. Bolkenstein, Esther C. J. Consten, Job van der Palen, Bryan J. M. van de Wall, Ivo A. M. J. Broeders, Willem A. Bemelman, Johan F. Lange, Marja A. Boermeester, Werner A. Draaisma. Long-term Outcome of Surgery Versus Conservative Management for Recurrent and Ongoing Complaints After an Episode of Diverticulitis. Annals of Surgery 2019; 269(4): 612 doi: 10.1097/SLA.0000000000003033
33
Brennan Spiegel. Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome. American Journal of Gastroenterology 2022; 117(12): 1933 doi: 10.14309/ajg.0000000000002066
34
Antonio Tursi. Balsalazide Plus High-potency Probiotic Preparation (VSL♯3) in the Treatment of Acute Mild-to-moderate Ulcerative Colitis and Uncomplicated Diverticulitis of the Colon. Journal of Clinical Gastroenterology 2008; 42(Supplement 3): S119 doi: 10.1097/MCG.0b013e31815f5ac7
35
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
36
Rocco Ricciardi, Susannah Clark, Patricia L. Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 1826 doi: 10.1016/B978-0-323-40232-3.00157-6
37
Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti, Walter Elisei. Transient Lactose Malabsorption in Patients Affected by Symptomatic Uncomplicated Diverticular Disease of the Colon. Digestive Diseases and Sciences 2006; 51(3): 461 doi: 10.1007/s10620-006-3155-6
38
Angèle P. M. Kerckhoffs, Maarten R. Visser, Melvin Samsom, Michel E. van der Rest, Joris de Vogel, Wil Harmsen, Louis M. A. Akkermans. Critical Evaluation of Diagnosing Bacterial Overgrowth in the Proximal Small Intestine. Journal of Clinical Gastroenterology 2008; 42(10): 1095 doi: 10.1097/MCG.0b013e31818474d7
39
Doron Boltin, Tsachi Tsadok Perets, Einav Shporn, Shoshana Aizic, Sigal Levy, Yaron Niv, Ram Dickman. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome. Annals of Clinical Microbiology and Antimicrobials 2014; 13(1) doi: 10.1186/s12941-014-0049-x
40
Bryan J M van de Wall, Marguerite A W Stam, Werner A Draaisma, R Stellato, Willem A Bemelman, Marja A Boermeester, Ivo A M J Broeders, Eric J Belgers, Boudewijn R Toorenvliet, Hubert A Prins, Esther C J Consten. Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology & Hepatology 2017; 2(1): 13 doi: 10.1016/S2468-1253(16)30109-1
41
Antonio Tursi, Raymond E. Joseph, Paul Streck. Expanding Applications: The Potential Usage of 5-Aminosalicylic Acid in Diverticular Disease. Digestive Diseases and Sciences 2011; 56(11): 3112 doi: 10.1007/s10620-011-1731-x
42
Sanjoy Ghosh, Erin Molcan, Daniella DeCoffe, Chaunbin Dai, Deanna L. Gibson. Diets rich inn-6 PUFA induce intestinal microbial dysbiosis in aged mice. British Journal of Nutrition 2013; 110(3): 515 doi: 10.1017/S0007114512005326
43
Antonio Tursi. Diverticulosis today: unfashionable and still under-researched. Therapeutic Advances in Gastroenterology 2016; 9(2): 213 doi: 10.1177/1756283X15621228
44
Brennan M. R. Spiegel, Mark W. Reid, Roger Bolus, Cynthia B. Whitman, Jennifer Talley, Stanley Dea, Kamyar Shahedi, Hetal Karsan, Chassidy Teal, Gil Y. Melmed, Erica Cohen, Garth Fuller, Linnette Yen, Paul Hodgkins, M. Haim Erder. Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL. Quality of Life Research 2015; 24(1): 163 doi: 10.1007/s11136-014-0753-1
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345